Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr;3(4):187-191.
doi: 10.1159/000495985. Epub 2019 Jan 30.

Subclinical Nasal and Lung Lymphocytosis in Ulcerative Colitis

Affiliations

Subclinical Nasal and Lung Lymphocytosis in Ulcerative Colitis

Maurizio Marvisi et al. Inflamm Intest Dis. 2019 Apr.

Abstract

Background: Extraintestinal manifestations are common in ulcerative colitis (UC). Data regarding pulmonary and nasal mucosa involvement are sparse.

Objectives: The aim of the study was to evaluate, by using induced sputum (IS) and nasal cytology (NC), the cytological pattern of the lung and nose in patients with UC.

Materials and methods: We enrolled 15 consecutive subjects from the outpatient department with a recent diagnosis of UC. On the same day of enrollment, we performed a global spirometry, including a lung diffusing capacity test, IS analysis, and evaluation of NC.

Results: IS analysis showed an increase in lymphocytes in UC patients when compared to those of controls (2.8 ± 0.9 vs. 0.2 ± 0.4%; p < 0.01). NC showed a similar increase in lymphocytes (12.5 ± 5.30 vs. 3.5 ± 4.0%; p < 0.01). We found a positive correlation between lymphocyte counts in IS and NC (r = 0.775; p < 0.001) and between lymphocytes in IS and NC and grade of intestinal inflammation (r = 0.603, p = 0.015; r = 0.60, p = 0.013).

Conclusions: Our data demonstrated that UC patients may have a subclinical nasal and lung lymphocytosis.

Keywords: Extraintestinal manifestations; Inflammatory bowel disease; Lung involvement; Lymphocytes; Nasal involvement; Ulcerative colitis.

PubMed Disclaimer

References

    1. Ott C, Scholmerich J. Extraintestinal manifestations and complications in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2013;10:585–95. - PubMed
    1. Papanikolaou I, Kagouridis K, Papiris SA. Patterns of airway involvement in inflammatory bowel diseases. World J Gastrointest Pathophysiol. 2014 Nov;5((4)):560–9. - PMC - PubMed
    1. Rodriguez Rosin R. Bartolome Sd, Huchon G, Krowka MJ. Inflammatory bowel disease, chronic liver disease and the lung. Eur Respir J. 2016;47:638–50. - PubMed
    1. Ji XQ, Wang LX, Lu DG. Pulmonary manifestations of IBD. World J Gastroenterol. 2014;20:13501–11. - PMC - PubMed
    1. D'Ippolito R, Foresi A, Chetta A, Casalini A, Castagnaro A, Leone C, et al. Induced sputum in patients with newly diagnosed sarcoidosis: comparison with bronchial wash and BAL. Chest. 1999 Jun;115((6)):1611–5. - PubMed